Anebulo Pharmaceuticals Inc is a biotechnology business based in the US. Anebulo Pharmaceuticals shares (ANEB) are listed on the NASDAQ and all prices are listed in US Dollars. Anebulo Pharmaceuticals employs 2 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Anebulo Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ANEB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Active traders

Anebulo Pharmaceuticals stock price (NASDAQ: ANEB)
Use our graph to track the performance of ANEB stocks over time.Anebulo Pharmaceuticals shares at a glance
Latest market close | $5.29 |
---|---|
52-week range | $2.67 - $7.89 |
50-day moving average | $3.63 |
200-day moving average | $5.93 |
Wall St. target price | $10.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.55 |
Buy Anebulo Pharmaceuticals shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Anebulo Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Anebulo Pharmaceuticals price performance over time
Historical closes compared with the close of $5.29 from 2022-07-05
1 week (2022-06-29) | 11.60% |
---|---|
1 month (2022-06-06) | 51.14% |
3 months (2022-04-06) | -18.62% |
6 months (2022-01-06) | -23.22% |
1 year (2021-07-06) | -21.04% |
---|---|
2 years (2020-07-02) | N/A |
3 years (2019-07-02) | N/A |
5 years (2017-07-02) | N/A |
Anebulo Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -18.3% |
Return on equity TTM | -249.85% |
Profit margin | 0% |
Book value | $0.74 |
Market capitalisation | $128.2 million |
TTM: trailing 12 months
Anebulo Pharmaceuticals share dividends
We're not expecting Anebulo Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (3.06% forward annual dividend yield)
- AstraZeneca PLC ADR (AZN.US) (2.17% forward annual dividend yield)
- AbbVie (ABBV.US) (3.68% forward annual dividend yield)
Anebulo Pharmaceuticals overview
Anebulo Pharmaceuticals, Inc. , a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas. .
Frequently asked questions
What percentage of Anebulo Pharmaceuticals is owned by insiders or institutions?Currently 75.551% of Anebulo Pharmaceuticals shares are held by insiders and 17.979% by institutions. How many people work for Anebulo Pharmaceuticals?
Latest data suggests 2 work at Anebulo Pharmaceuticals. When does the fiscal year end for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals's fiscal year ends in December. Where is Anebulo Pharmaceuticals based?
Anebulo Pharmaceuticals's address is: 1415 Ranch Road 620 South, Lakeway, TX, United States, 78734 What is Anebulo Pharmaceuticals's ISIN number?
Anebulo Pharmaceuticals's international securities identification number is: US0345691036
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert